应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INKT MiNK Therapeutics, Inc.
已收盘 07-11 16:00:00 EDT
64.17
+56.44
+730.14%
盘后
51.20
-12.97
-20.21%
19:59 EDT
最高
76.00
最低
20.20
成交量
4,786万
今开
21.07
昨收
7.73
日振幅
721.86%
总市值
2.56亿
流通市值
6,525万
总股本
398.57万
成交额
24.43亿
换手率
4,706.79%
流通股本
101.68万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
生物医药股INKT飙涨逾730%!公司宣布其药物在实体瘤治疗领域显示巨大潜力
老虎资讯综合 · 07-11 23:24
生物医药股INKT飙涨逾730%!公司宣布其药物在实体瘤治疗领域显示巨大潜力
Mink Therapeutics, Inc.2025财年第一财季实现净利润-2.77百万美元,同比增加27.30%
市场透视 · 05-23
Mink Therapeutics, Inc.2025财年第一财季实现净利润-2.77百万美元,同比增加27.30%
Mink Therapeutics, Inc.盘中异动 大幅跳水5.79%报7.16美元
市场透视 · 05-20
Mink Therapeutics, Inc.盘中异动 大幅跳水5.79%报7.16美元
Mink Therapeutics, Inc.盘中异动 临近收盘急速拉升5.01%报7.54美元
市场透视 · 05-16
Mink Therapeutics, Inc.盘中异动 临近收盘急速拉升5.01%报7.54美元
Mink Therapeutics, Inc.盘中异动 快速上涨6.40%
市场透视 · 05-15
Mink Therapeutics, Inc.盘中异动 快速上涨6.40%
Mink Therapeutics, Inc.盘中异动 早盘股价大涨5.76%报7.71美元
市场透视 · 05-14
Mink Therapeutics, Inc.盘中异动 早盘股价大涨5.76%报7.71美元
Mink Therapeutics, Inc.盘中异动 早盘快速下跌9.82%
市场透视 · 05-12
Mink Therapeutics, Inc.盘中异动 早盘快速下跌9.82%
Mink Therapeutics, Inc.盘中异动 大幅上涨5.89%
市场透视 · 05-09
Mink Therapeutics, Inc.盘中异动 大幅上涨5.89%
Mink Therapeutics, Inc.盘中异动 大幅上涨5.72%报7.68美元
市场透视 · 04-22
Mink Therapeutics, Inc.盘中异动 大幅上涨5.72%报7.68美元
Mink Therapeutics, Inc.盘中异动 早盘急速跳水8.05%
市场透视 · 03-10
Mink Therapeutics, Inc.盘中异动 早盘急速跳水8.05%
Mink Therapeutics, Inc.盘中异动 股价大涨6.30%
市场透视 · 03-05
Mink Therapeutics, Inc.盘中异动 股价大涨6.30%
Mink Therapeutics, Inc.盘中异动 快速下挫9.47%
市场透视 · 03-04
Mink Therapeutics, Inc.盘中异动 快速下挫9.47%
Mink Therapeutics, Inc.盘中异动 早盘快速拉升5.30%
市场透视 · 02-21
Mink Therapeutics, Inc.盘中异动 早盘快速拉升5.30%
Mink Therapeutics, Inc.盘中异动 早盘大幅上涨6.43%
市场透视 · 02-11
Mink Therapeutics, Inc.盘中异动 早盘大幅上涨6.43%
Mink Therapeutics, Inc.盘中异动 快速拉升5.67%报11.47美元
市场透视 · 02-06
Mink Therapeutics, Inc.盘中异动 快速拉升5.67%报11.47美元
Mink Therapeutics, Inc.盘中异动 早盘大幅下跌6.87%
市场透视 · 02-04
Mink Therapeutics, Inc.盘中异动 早盘大幅下跌6.87%
Mink Therapeutics, Inc.盘中异动 早盘快速跳水5.24%报8.68美元
市场透视 · 02-03
Mink Therapeutics, Inc.盘中异动 早盘快速跳水5.24%报8.68美元
Mink Therapeutics, Inc.盘中异动 早盘股价大涨6.06%报7.00美元
市场透视 · 01-30
Mink Therapeutics, Inc.盘中异动 早盘股价大涨6.06%报7.00美元
Mink Therapeutics, Inc.盘中异动 急速跳水6.91%
市场透视 · 01-27
Mink Therapeutics, Inc.盘中异动 急速跳水6.91%
加载更多
公司概况
公司名称:
MiNK Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
MiNK Therapeutics, Inc.于2017年7月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,率先发现、开发和商业化同种异体、现成的iNKT细胞疗法,以治疗癌症和其他免疫介导的疾病。该公司正在利用其平台和制造能力开发一条全资或独家许可的天然和工程iNKT细胞管道,并预计在2021年和2022年进行多项临床和临床前读数。公司的战略是推进可访问、可扩展且有效的细胞治疗平台,利用iNKT细胞的先天和持久的生物学优势,优化可扩展性和快速临床开发。
发行价格:
--
{"stockData":{"symbol":"INKT","market":"US","secType":"STK","nameCN":"MiNK Therapeutics, Inc.","latestPrice":64.17,"timestamp":1752264000000,"preClose":7.73,"halted":0,"volume":47857585,"hourTrading":{"tag":"盘后","latestPrice":51.2,"preClose":64.17,"latestTime":"19:59 EDT","volume":943537,"amount":50998044.9824,"timestamp":1752278398966},"delay":0,"floatShares":1016778,"shares":3985657,"eps":-2.497936,"marketStatus":"已收盘","change":56.44,"latestTime":"07-11 16:00:00 EDT","open":21.07,"high":76,"low":20.2,"amount":2442542980.2578998,"amplitude":7.218629,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.497936,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":5,"adr":0,"listingDate":1634270400000,"exchange":"NASDAQ","adjPreClose":7.73,"preHourTrading":{"tag":"盘前","latestPrice":20.92,"preClose":7.73,"latestTime":"09:29 EDT","volume":2645431,"amount":62328507.740834005,"timestamp":1752240599720},"postHourTrading":{"tag":"盘后","latestPrice":51.2,"preClose":64.17,"latestTime":"19:59 EDT","volume":943537,"amount":50998044.9824,"timestamp":1752278398966},"volumeRatio":17869.310879},"requestUrl":"/m/hq/s/INKT","defaultTab":"news","newsList":[{"id":"1112653329","title":"生物医药股INKT飙涨逾730%!公司宣布其药物在实体瘤治疗领域显示巨大潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1112653329","media":"老虎资讯综合","labels":["dataReport"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112653329?lang=zh_cn&edition=full","pubTime":"2025-07-12 07:24","pubTimestamp":1752276241,"startTime":"0","endTime":"0","summary":"7月12日,$MiNK Therapeutics$飙涨730%,成交24.41亿美元。治疗过程显示:该患者历经多线治疗均无效后,接受单次agenT-797输注联合百时美$施贵宝$Opdivo治疗。该案例为日益丰富的临床证据再添力证,表明agenT-797在实体瘤治疗领域具有显著潜力。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"生物医药股INKT飙涨逾730%!公司宣布其药物在实体瘤治疗领域显示巨大潜力","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT"],"gpt_icon":0},{"id":"2537153251","title":"Mink Therapeutics, Inc.2025财年第一财季实现净利润-2.77百万美元,同比增加27.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537153251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537153251?lang=zh_cn&edition=full","pubTime":"2025-05-24 00:00","pubTimestamp":1748016032,"startTime":"0","endTime":"0","summary":"5月24日,Mink Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为-2.77百万美元,同比增加27.30%;其中营业收入为0.00美元,每股基本收益为-0.70美元。从资产负债表来看,Mink Therapeutics, Inc.总负债26.06百万美元,其中短期债务5.12百万美元,资产负债比为0.17,流动比率为0.30。机构评级:截至2025年5月24日,当前有1家机构对Mink Therapeutics, Inc.目标价做出预测,其中目标均价为35.00美元,其中最低目标价为35.00美元,最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000058a6ea7cd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000058a6ea7cd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","LENZ"],"gpt_icon":0},{"id":"2536364671","title":"Mink Therapeutics, Inc.盘中异动 大幅跳水5.79%报7.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536364671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536364671?lang=zh_cn&edition=full","pubTime":"2025-05-20 22:37","pubTimestamp":1747751820,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日22时37分,Mink Therapeutics, Inc.股票出现异动,股价大幅下挫5.79%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,开创了异基因不变自然杀伤T细胞疗法的发现、开发和商业化,以治疗癌症和其他免疫介导的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520223700a6e63143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520223700a6e63143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INKT","BK4539","BK4007"],"gpt_icon":0},{"id":"2536340389","title":"Mink Therapeutics, Inc.盘中异动 临近收盘急速拉升5.01%报7.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536340389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536340389?lang=zh_cn&edition=full","pubTime":"2025-05-17 04:02","pubTimestamp":1747425735,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日04时02分,Mink Therapeutics, Inc.股票出现异动,股价急速上涨5.01%。截至发稿,该股报7.54美元/股,成交量1575股,换手率0.04%,振幅0.00%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.48%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,开创了异基因不变自然杀伤T细胞疗法的发现、开发和商业化,以治疗癌症和其他免疫介导的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051704021594f94c48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051704021594f94c48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2535829049","title":"Mink Therapeutics, Inc.盘中异动 快速上涨6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535829049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535829049?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:34","pubTimestamp":1747316048,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时34分,Mink Therapeutics, Inc.股票出现异动,股价急速拉升6.40%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,开创了异基因不变自然杀伤T细胞疗法的发现、开发和商业化,以治疗癌症和其他免疫介导的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213408a47fa6eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213408a47fa6eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","INKT"],"gpt_icon":0},{"id":"2535407666","title":"Mink Therapeutics, Inc.盘中异动 早盘股价大涨5.76%报7.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535407666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535407666?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:39","pubTimestamp":1747233546,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日22时39分,Mink Therapeutics, Inc.股票出现波动,股价大幅拉升5.76%。截至发稿,该股报7.71美元/股,成交量4799股,换手率0.12%,振幅8.80%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.37%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,开创了异基因不变自然杀伤T细胞疗法的发现、开发和商业化,以治疗癌症和其他免疫介导的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514223906a47e4d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514223906a47e4d1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4539","INKT","BK4139"],"gpt_icon":0},{"id":"2534472208","title":"Mink Therapeutics, Inc.盘中异动 早盘快速下跌9.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534472208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534472208?lang=zh_cn&edition=full","pubTime":"2025-05-12 22:48","pubTimestamp":1747061295,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日22时48分,Mink Therapeutics, Inc.股票出现波动,股价快速跳水9.82%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.80%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,开创了异基因不变自然杀伤T细胞疗法的发现、开发和商业化,以治疗癌症和其他免疫介导的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512224815aa2c8ba3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512224815aa2c8ba3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","INKT"],"gpt_icon":0},{"id":"2534438753","title":"Mink Therapeutics, Inc.盘中异动 大幅上涨5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534438753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534438753?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:53","pubTimestamp":1746798791,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时53分,Mink Therapeutics, Inc.股票出现波动,股价急速上涨5.89%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,开创了异基因不变自然杀伤T细胞疗法的发现、开发和商业化,以治疗癌症和其他免疫介导的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509215312a6d93245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509215312a6d93245&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2529535482","title":"Mink Therapeutics, Inc.盘中异动 大幅上涨5.72%报7.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529535482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529535482?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:28","pubTimestamp":1745335731,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时28分,Mink Therapeutics, Inc.股票出现波动,股价急速拉升5.72%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.81%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,开创了异基因不变自然杀伤T细胞疗法的发现、开发和商业化,以治疗癌症和其他免疫介导的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042223285194de50ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042223285194de50ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2518308222","title":"Mink Therapeutics, Inc.盘中异动 早盘急速跳水8.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518308222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518308222?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:44","pubTimestamp":1741614241,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时44分,Mink Therapeutics, Inc.股票出现异动,股价快速跳水8.05%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。其相关个股中,Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2390.07%、561.77%、84.34%,振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.,振幅分别为40.24%、28.59%、25.35%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214401abf30117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214401abf30117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2517947192","title":"Mink Therapeutics, Inc.盘中异动 股价大涨6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517947192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517947192?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:42","pubTimestamp":1741196552,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时42分,Mink Therapeutics, Inc.股票出现异动,股价大幅拉升6.30%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.25%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014232963b06ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014232963b06ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INKT","LENZ"],"gpt_icon":0},{"id":"2516677322","title":"Mink Therapeutics, Inc.盘中异动 快速下挫9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677322?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:30","pubTimestamp":1741098649,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时30分,Mink Therapeutics, Inc.股票出现波动,股价急速跳水9.47%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223050989bab88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223050989bab88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2513629652","title":"Mink Therapeutics, Inc.盘中异动 早盘快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513629652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513629652?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:34","pubTimestamp":1740148490,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时34分,Mink Therapeutics, Inc.股票出现波动,股价急速上涨5.30%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223450abd7b04e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223450abd7b04e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INKT","BK4139"],"gpt_icon":0},{"id":"2510380389","title":"Mink Therapeutics, Inc.盘中异动 早盘大幅上涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380389?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:32","pubTimestamp":1739284345,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时32分,Mink Therapeutics, Inc.股票出现异动,股价快速拉升6.43%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.10%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223227961f47be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223227961f47be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INKT","LENZ"],"gpt_icon":0},{"id":"2509277498","title":"Mink Therapeutics, Inc.盘中异动 快速拉升5.67%报11.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509277498?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:44","pubTimestamp":1738853044,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时44分,Mink Therapeutics, Inc.股票出现异动,股价快速拉升5.67%。截至发稿,该股报11.47美元/股,成交量9870股,换手率0.25%,振幅8.02%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224404a23bd15a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224404a23bd15a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2508457999","title":"Mink Therapeutics, Inc.盘中异动 早盘大幅下跌6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508457999?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:38","pubTimestamp":1738679939,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时38分,Mink Therapeutics, Inc.股票出现异动,股价快速跳水6.87%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223859987a4b93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223859987a4b93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INKT","LENZ"],"gpt_icon":0},{"id":"2508149126","title":"Mink Therapeutics, Inc.盘中异动 早盘快速跳水5.24%报8.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149126?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593129,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分,Mink Therapeutics, Inc.股票出现异动,股价快速跳水5.24%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.51%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223209abc106da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223209abc106da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2507621300","title":"Mink Therapeutics, Inc.盘中异动 早盘股价大涨6.06%报7.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507621300?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:38","pubTimestamp":1738247912,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时38分,Mink Therapeutics, Inc.股票出现异动,股价急速上涨6.06%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223832abbd4dc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223832abbd4dc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2506067583","title":"Mink Therapeutics, Inc.盘中异动 急速跳水6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506067583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506067583?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:12","pubTimestamp":1737990775,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时12分,Mink Therapeutics, Inc.股票出现异动,股价快速跳水6.91%。Mink Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.02%。Mink Therapeutics, Inc.公司简介:.MiNK Therapeutics Inc是一家临床阶段的生物制药公司,专注开发同种异体不变的自然杀伤T细胞疗法,以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127231255abba6883&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127231255abba6883&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minktherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0689},{"period":"1month","weight":0.02},{"period":"3month","weight":-0.0709},{"period":"6month","weight":0.0575},{"period":"1year","weight":-0.1115},{"period":"ytd","weight":0.1092}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MiNK Therapeutics, Inc.于2017年7月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,率先发现、开发和商业化同种异体、现成的iNKT细胞疗法,以治疗癌症和其他免疫介导的疾病。该公司正在利用其平台和制造能力开发一条全资或独家许可的天然和工程iNKT细胞管道,并预计在2021年和2022年进行多项临床和临床前读数。公司的战略是推进可访问、可扩展且有效的细胞治疗平台,利用iNKT细胞的先天和持久的生物学优势,优化可扩展性和快速临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.065869},{"month":2,"riseRate":0.25,"avgChangeRate":-0.041821},{"month":3,"riseRate":0,"avgChangeRate":-0.089419},{"month":4,"riseRate":0.25,"avgChangeRate":-0.026851},{"month":5,"riseRate":0,"avgChangeRate":-0.100407},{"month":6,"riseRate":0.5,"avgChangeRate":0.033071},{"month":7,"riseRate":0.25,"avgChangeRate":-0.035948},{"month":8,"riseRate":0.333333,"avgChangeRate":0.214912},{"month":9,"riseRate":0,"avgChangeRate":-0.171057},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.029184},{"month":11,"riseRate":0.75,"avgChangeRate":-0.020151},{"month":12,"riseRate":0.25,"avgChangeRate":-0.165057}],"exchange":"NASDAQ","name":"MiNK Therapeutics, Inc.","nameEN":"MiNK Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MiNK Therapeutics, Inc.(INKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MiNK Therapeutics, Inc.(INKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MiNK Therapeutics, Inc.,INKT,MiNK Therapeutics, Inc.股票,MiNK Therapeutics, Inc.股票老虎,MiNK Therapeutics, Inc.股票老虎国际,MiNK Therapeutics, Inc.行情,MiNK Therapeutics, Inc.股票行情,MiNK Therapeutics, Inc.股价,MiNK Therapeutics, Inc.股市,MiNK Therapeutics, Inc.股票价格,MiNK Therapeutics, Inc.股票交易,MiNK Therapeutics, Inc.股票购买,MiNK Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MiNK Therapeutics, Inc.(INKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MiNK Therapeutics, Inc.(INKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}